High-dose tramadol conversion to buprenorphine-naloxone

Area of Science:

• Pharmacology
• Addiction Medicine

Background:

• Buprenorphine-naloxone is effective for opioid use disorder (OUD).
• Tramadol, a centrally acting analgesic, has complex mechanisms including opioid receptor agonism and neurotransmitter reuptake inhibition.
• The transition from high-dose tramadol to buprenorphine-naloxone is not well-documented.

Observation:

• A patient presented with daily tramadol intake of 1,000-1,250 mg, significantly exceeding the initial prescription.
• This high dosage developed over a 10-year period due to dose and frequency escalation.
• The patient was successfully converted to buprenorphine-naloxone therapy.

Findings:

• The conversion from high-dose tramadol to buprenorphine-naloxone was clinically successful.
• The patient has maintained successful treatment for OUD for one year post-conversion.

Implications:

• This case suggests buprenorphine-naloxone is a viable option for managing OUD in patients with a history of high-dose tramadol use.
• Further research is warranted to explore this transition strategy in a larger patient cohort.
• This case highlights the importance of considering alternative OUD treatment pathways for patients with complex medication histories.